MCAT Biological and Biochemical Foundations of Living Systems Quiz: 3b Skeletal System Mineral Homeostasis

What this quiz covers

This quiz focuses on 3b Skeletal System Mineral Homeostasis, giving you a quick way to practice the rules, question types, and explanations that matter most for MCAT Biological and Biochemical Foundations of Living Systems.

How to use this quiz

Try each quiz question before looking at the correct answer. Use the explanations to review missed ideas, then come back to similar questions until the pattern feels familiar.

Question 1

1. Increased calcitonin leading to decreased osteoclast activity
2. Decreased PTH leading to decreased osteoclast activity
3. Increased PTH leading to increased net bone resorption (correct answer)
4. Increased osteoblast activity leading to increased mineral deposition into bone

Explanation: This question tests mineral homeostasis, specifically skeletal compensation for minor calcium declines. The skeletal system restores plasma Ca2+ by osteoclast resorption releasing minerals, opposed by osteoblast deposition, with PTH favoring resorption in hypocalcemia. During fasting, slight Ca2+ drops trigger a hormonal response to mobilize bone stores. The correct change, increased PTH leading to increased net resorption, logically raises plasma Ca2+ via enhanced osteoclast activity. A distractor like increased calcitonin fails by applying high-Ca2+ responses to low-Ca2+ scenarios, a common confusion in feedback directions. In similar physiological reasoning, map the stimulus to the hormone and then to bone cell effects. Validate by predicting the directional change in plasma minerals.

Question 2

1. Increased osteoblast activity and increased local bone mineral density due to reduced microdamage
2. Decreased osteoclast activity and decreased Ca2+ release to plasma
3. Increased osteoclast activity and decreased bone mineral density due to reduced mechanical stimulation (correct answer)
4. No change in remodeling because mineral homeostasis is regulated only by dietary intake

Explanation: This question evaluates mineral homeostasis, particularly how mechanical loading influences skeletal mineral regulation. The skeletal system adapts to loading by modulating osteoclast resorption, which releases minerals, and osteoblast formation, which deposits them, with reduced loading favoring resorption. Immobilization of one leg decreases mechanical stimulation, shifting remodeling toward net mineral loss in the affected limb. The correct answer, increased osteoclast activity and decreased BMD, logically results from unloading-induced resorption to release Ca2+ and Pi. A distractor like increased osteoblast activity fails by mistakenly assuming unloading stimulates formation, ignoring mechanotransduction principles. For analogous problems, compare loaded versus unloaded conditions and predict resorption dominance in disuse. Consider hormonal overlays but prioritize mechanical effects when specified.

Question 3

1. Increased bone mineral density due to sustained osteoblast stimulation
2. Decreased bone mineral density due to sustained net bone resorption (correct answer)
3. No change in bone mineral density because PTH affects only calcitonin secretion
4. Decreased plasma Ca2+ due to decreased osteoclast activity

Explanation: This question probes mineral homeostasis, particularly long-term skeletal effects of elevated PTH. The skeletal system maintains minerals through osteoclast resorption releasing Ca2+ and Pi, and osteoblast formation storing them, with PTH favoring resorption. Chronically high PTH persistently shifts toward net mineral loss from bone. The correct outcome, decreased BMD due to sustained resorption, logically results from prolonged osteoclast dominance. A distractor like increased BMD fails by confusing PTH with anabolic signals, a misconception from intermittent dosing contexts. For chronic conditions, evaluate cumulative remodeling imbalance. Relate hormone levels to expected plasma and bone changes.

Question 4

1. Decreased plasma Ca2+ and decreased plasma Pi due to increased mineral deposition
2. Increased plasma Ca2+ and increased plasma Pi due to increased bone resorption (correct answer)
3. Increased plasma Ca2+ and decreased plasma Pi because PTH releases only calcium from bone
4. No change in plasma minerals because PTH acts only on osteoblasts to form bone

Explanation: This question evaluates mineral homeostasis, exploring PTH agonism's impact on skeletal mineral release. The skeletal system increases plasma minerals through PTH-enhanced osteoclast resorption of Ca2+ and Pi. Administering a PTH receptor agonist promotes net bone breakdown in the model. The correct change, increased plasma Ca2+ and Pi due to resorption, logically elevates both ions proportionally. A distractor like increased Ca2+ but decreased Pi fails by assuming selective release, a misconception from renal effects. In pharmacology, connect agonist to target pathway and outcomes. Verify both minerals' involvement in bone hydroxyapatite.

Question 5

1. Hypercalcemia due to reduced mineral deposition into bone
2. Hypocalcemia due to reduced mineral release from bone stores (correct answer)
3. Hyperphosphatemia due to increased phosphate release during resorption
4. No change in plasma Ca2+ because only calcitonin controls blood calcium

Explanation: This question probes mineral homeostasis, examining consequences of impaired skeletal mineral mobilization. The skeletal system supplies plasma Ca2+ primarily through osteoclast resorption, with reduced function limiting release. A mutation decreasing osteoclast activity hinders Ca2+ provision from bone stores. The correct disturbance, hypocalcemia due to reduced release, follows assuming fixed intake. A distractor like hypercalcemia fails by reversing the flux direction, misconstruing resorption's role. For genetic vignettes, predict loss-of-function effects on homeostasis. Account for compensatory mechanisms but prioritize direct impact.

Question 6

1. Low PTH is inappropriate because PTH should rise to lower plasma Ca2+
2. Low PTH is appropriate because reduced PTH helps decrease osteoclast-mediated Ca2+ release (correct answer)
3. Low PTH is appropriate because PTH directly inhibits osteoclasts during hypercalcemia
4. Low PTH indicates bone formation must be increased by activating osteoclasts

Explanation: This question tests mineral homeostasis, interpreting hormone levels in skeletal context during hypercalcemia. The skeletal system reduces Ca2+ release by lowering PTH to decrease osteoclast activity. Hypercalcemia with low PTH represents appropriate suppression to limit resorption. The correct interpretation, low PTH appropriate to decrease Ca2+ release, follows negative feedback principles. A distractor like low PTH inappropriate fails by applying hypocalcemic responses, a feedback direction error. In clinical patterns, match hormone to ion state expectedly. Distinguish primary from secondary disorders.

Question 7

1. Increased osteoclast activity and increased mineral release to plasma
2. Decreased osteoclast activity and decreased mineral release to plasma (correct answer)
3. Decreased osteoblast activity and increased mineral deposition into bone
4. Increased osteoblast activity and increased mineral release to plasma

Explanation: This question probes mineral homeostasis, linking hormone shifts to skeletal remodeling outcomes. The skeletal system decreases mineral release when high Ca2+ raises calcitonin and lowers PTH, inhibiting osteoclasts. Elevated Ca2+ prompts decreased osteoclast activity, reducing ion influx to plasma. The correct outcome, decreased osteoclast and decreased release, follows combined hormone effects. A distractor like increased osteoblast release fails by confusing cell functions. In multi-hormone scenarios, integrate effects on target cells. Verify consistency with homeostasis restoration.

Question 8

1. Condition 1, because increased PTH promotes osteoclast-mediated resorption (correct answer)
2. Condition 1, because calcitonin is increased and stimulates osteoclasts
3. Condition 2, because increased calcitonin promotes osteoclast-mediated resorption
4. Condition 2, because PTH rises in response to high Ca2+ to normalize levels

Explanation: This question tests mineral homeostasis, contrasting skeletal responses to low versus high calcium environments. The skeletal system adjusts via PTH promoting resorption in low Ca2+ and calcitonin inhibiting it in high Ca2+. In culture, low extracellular Ca2+ (Condition 1) elicits greater mineral release than high Ca2+ (Condition 2). The correct choice, Condition 1 due to increased PTH promoting resorption, follows as low Ca2+ triggers PTH to enhance osteoclast activity. A distractor like Condition 2 with increased calcitonin promoting resorption fails by reversing calcitonin's inhibitory role, a common error. In comparisons, link conditions to hormone triggers and bone outcomes. Predict mineral flux based on homeostasis goals.

Question 9

1. Increased PTH secretion to promote osteoclast activation and raise Ca2+ further
2. Decreased calcitonin secretion to increase bone resorption and restore baseline Ca2+
3. Decreased PTH secretion and increased calcitonin secretion to reduce osteoclast-mediated resorption (correct answer)
4. No change in PTH or calcitonin because bone mineral content buffers Ca2+ independently of hormones

Explanation: This question tests understanding of mineral homeostasis, specifically how the skeletal system responds to changes in plasma calcium levels through hormonal regulation. The skeletal system regulates minerals by balancing osteoclast-mediated bone resorption, which releases calcium and phosphate into the blood, and osteoblast-mediated bone formation, which deposits these minerals into bone. In this scenario, an intravenous calcium infusion raises plasma Ca2+ above baseline, triggering a feedback response to restore homeostasis. The correct answer, decreased PTH secretion and increased calcitonin secretion, follows logically because high Ca2+ suppresses PTH to reduce resorption and stimulates calcitonin to inhibit osteoclast activity, thereby lowering Ca2+ release from bone. A distractor like increased PTH secretion fails because it reflects a common misconception that PTH always promotes Ca2+ elevation, ignoring its suppression during hypercalcemia. To verify similar physiological reasoning, always identify the direction of the mineral imbalance and recall that PTH responds to low Ca2+ while calcitonin counters high Ca2+. Additionally, consider the net effect on bone remodeling to predict plasma mineral changes.

Question 10

1. Decreased Ca2+ and Pi in the medium due to accelerated mineral deposition
2. Increased Ca2+ and Pi in the medium due to accelerated bone resorption (correct answer)
3. Increased Ca2+ in the medium but decreased Pi due to selective phosphate uptake by osteoclasts
4. No change in Ca2+ or Pi because osteoclasts primarily remodel collagen, not mineral

Explanation: This question tests knowledge of mineral homeostasis, focusing on the roles of osteoclasts and osteoblasts in skeletal mineral regulation. The skeletal system maintains mineral balance through osteoclast resorption, which releases Ca2+ and phosphate into the extracellular fluid, and osteoblast formation, which removes these ions for bone deposition. Here, increased osteoclast activity without compensatory osteoblast changes shifts remodeling toward resorption in a bone culture model. The correct outcome of increased Ca2+ and Pi in the medium follows logically as osteoclasts accelerate mineral release from bone slices. A distractor like decreased Ca2+ and Pi fails due to the misconception that osteoclasts deposit minerals, confusing their resorptive role with osteoblast function. For similar tasks, confirm the primary action of each cell type and assess net mineral flux direction. Always evaluate if the scenario alters one process independently to predict extracellular ion changes.

Question 11

1. Low PTH leading to reduced osteoclast-mediated Ca2+ release from bone (correct answer)
2. High PTH leading to reduced osteoclast-mediated Ca2+ release from bone
3. Low calcitonin leading to reduced osteoclast activity and reduced Ca2+ release
4. High calcitonin leading to increased osteoclast activity and increased Ca2+ release

Explanation: This question probes mineral homeostasis, focusing on hormonal control of skeletal responses to hypocalcemia. The skeletal system maintains plasma Ca2+ through osteoclast resorption releasing minerals and osteoblast formation storing them, with PTH enhancing resorption during low Ca2+. Post-surgery hypocalcemia persists likely due to parathyroid damage, impairing PTH secretion. The correct pattern, low PTH leading to reduced osteoclast-mediated Ca2+ release, logically explains the failure to compensate via bone resorption. A distractor like high PTH with reduced release fails by overlooking that high PTH actually increases resorption, a common mix-up in feedback loops. In similar cases, identify if the hormone level matches the expected response to the ion imbalance. Cross-check surgical context for potential gland involvement affecting hormone availability.

Question 12

1. Increased PTH and decreased calcitonin to further increase plasma Ca2+
2. Decreased PTH and increased calcitonin to limit additional bone resorption (correct answer)
3. Increased PTH and increased calcitonin because both hormones rise with high Ca2+
4. No change in either hormone because osteoclasts do not affect plasma Ca2+

Explanation: This question examines mineral homeostasis, focusing on hormonal feedback to skeletal perturbations. The skeletal system influences plasma via osteoclast release of minerals, modulated by PTH and calcitonin. An agent increasing osteoclast activity raises plasma Ca2+, eliciting a response to curb further elevation. The correct response, decreased PTH and increased calcitonin, logically limits resorption through hormone adjustments. A distractor like increased PTH fails by perpetuating hypercalcemia, misconstruing feedback as positive. In drug-induced changes, trace initial effect to ion shift then to hormones. Ensure alignment with restoring equilibrium.

Question 13

1. Increased plasma Ca2+ and Pi due to increased mineral deposition
2. Decreased plasma Ca2+ and Pi due to increased mineral deposition into bone (correct answer)
3. Decreased plasma Ca2+ but increased plasma Pi because osteoblasts selectively deposit calcium
4. No change in plasma minerals because osteoblasts only synthesize collagen matrix

Explanation: This question evaluates mineral homeostasis, emphasizing osteoblast contributions to skeletal mineral flux. The skeletal system regulates blood minerals via osteoblast deposition of Ca2+ and Pi into bone, balancing osteoclast release. Selective osteoblast activation, with constant osteoclasts, increases mineral removal from plasma. The correct change, decreased plasma Ca2+ and Pi due to deposition, follows as enhanced formation sequesters ions into bone. A distractor like no change fails by assuming osteoblasts only handle collagen, overlooking their mineralization role. In similar experiments, isolate the altered process and trace ion movement. Confirm assumptions like constant diet to isolate skeletal effects.

Question 14

1. Increased BMD due to direct incorporation of excess phosphate into hydroxyapatite regardless of hormones
2. Decreased BMD due to increased PTH-driven resorption to restore plasma Ca2+ (correct answer)
3. No change in BMD because calcitonin is maximally secreted whenever dietary phosphate increases
4. Decreased BMD due to decreased osteoclast activity causing reduced mineral release to plasma

Explanation: This question assesses mineral homeostasis, emphasizing skeletal responses to dietary phosphate excess and its impact on calcium regulation. The skeletal system buffers plasma minerals via osteoclast resorption releasing Ca2+ and Pi, and osteoblast formation storing them, with hormones adjusting the balance. A high-phosphate diet lowers free plasma Ca2+ by complexation, prompting a compensatory increase in PTH. The correct answer, decreased BMD due to PTH-driven resorption, logically follows as PTH promotes osteoclast activity to restore Ca2+, reducing bone mineral content. A distractor like increased BMD fails by misconstruing that excess phosphate directly builds bone without hormonal mediation. In similar scenarios, check how the perturbation affects Ca2+ sensing and subsequent PTH response. Verify the short-term net effect on bone density versus long-term adaptations.

Question 15

1. Decreased serum Ca2+ due to increased deposition of hydroxyapatite by osteoclasts
2. Increased serum Ca2+ and phosphate due to increased bone resorption (correct answer)
3. Increased bone mineral density due to accelerated osteoid formation
4. No change in extracellular minerals because bone does not participate in mineral buffering

Explanation: This question assesses knowledge of osteoclast function in mineral homeostasis and bone remodeling. The skeletal system dynamically regulates mineral levels through the coordinated actions of osteoclasts (which resorb bone and release minerals) and osteoblasts (which form bone and store minerals). The cytokine treatment specifically increases osteoclast activity, leading to enhanced breakdown of hydroxyapatite in mineralized bone matrix. This resorption process releases both calcium and phosphate ions into the extracellular fluid, increasing their serum concentrations. Choice A incorrectly attributes hydroxyapatite deposition to osteoclasts rather than osteoblasts, while choice C wrongly suggests increased bone density from enhanced resorption. To verify answers in bone cell questions, match the cell type to its function: osteoclasts break down bone (releasing minerals), while osteoblasts build bone (storing minerals).

Question 16

1. Low serum Ca2+ and high serum phosphate due to reduced bone resorption
2. High serum Ca2+ and low serum phosphate due to increased resorption and phosphate excretion (correct answer)
3. High serum Ca2+ and high serum phosphate because PTH increases renal phosphate reabsorption
4. Normal serum Ca2+ and phosphate because PTH has no effect on mineral balance

Explanation: This question assesses understanding of chronic PTH elevation effects on mineral homeostasis. The skeletal system's mineral regulation involves PTH's dual action: increasing calcium through bone resorption while decreasing phosphate through renal excretion. Chronically elevated PTH continuously stimulates osteoclast-mediated bone resorption, releasing both calcium and phosphate from bone, which raises serum calcium. However, PTH simultaneously increases renal phosphate excretion, preventing phosphate accumulation and maintaining an appropriate calcium-phosphate product to avoid soft tissue calcification. Choice A only addresses calcium without considering phosphate, while choice C incorrectly states PTH increases phosphate reabsorption when it actually increases excretion. When analyzing PTH effects, remember its coordinated actions: it raises calcium through multiple mechanisms while specifically lowering phosphate through renal losses, creating the characteristic high calcium/low phosphate pattern.

Question 17

1. Increased PTH secretion to stimulate osteoclasts and raise serum Ca2+ further
2. Decreased calcitonin secretion to promote bone resorption and release Ca2+
3. Increased calcitonin secretion to inhibit osteoclast-mediated bone resorption (correct answer)
4. No hormonal change because bone remodeling is independent of serum mineral levels

Explanation: This question tests recognition of calcitonin's role in responding to hypercalcemia and maintaining mineral homeostasis. The skeletal system participates in rapid mineral buffering through hormonal regulation of bone cell activity. When serum calcium rises above normal, as in this infusion scenario, calcium-sensing receptors in the thyroid's parafollicular cells detect the elevation and trigger calcitonin release. Calcitonin acts directly on osteoclasts to inhibit their bone-resorbing activity, preventing further calcium release from bone and allowing other mechanisms to normalize serum calcium. Choice A incorrectly suggests PTH increases when calcium is already high, while choice B wrongly implies decreased calcitonin would help lower calcium through increased resorption. For calcium regulation questions, apply the opposing actions rule: PTH responds to low calcium by increasing it, while calcitonin responds to high calcium by preventing further increases.

Question 18

1. Increased bone mineral density because calcitonin rises in response to low ionized Ca2+
2. Increased bone mineral density because phosphate directly activates osteoblasts to mineralize bone
3. No change in bone mineral density because PTH decreases bone resorption when phosphate is high
4. Decreased bone mineral density due to PTH-stimulated bone resorption (correct answer)

Explanation: This question evaluates understanding of phosphate-calcium interactions and compensatory PTH responses in mineral homeostasis. The skeletal system maintains mineral balance through hormonal regulation, with PTH serving as the primary defender of calcium homeostasis. High dietary phosphate binds free calcium ions, forming calcium-phosphate complexes that reduce ionized calcium levels, which triggers PTH release from the parathyroid glands. The elevated PTH stimulates osteoclast-mediated bone resorption to liberate calcium (and phosphate) from bone, while simultaneously increasing renal phosphate excretion to restore the calcium-phosphate balance. Choice B incorrectly suggests phosphate directly activates osteoblasts, while choice C wrongly states PTH decreases resorption when phosphate is high. When analyzing mineral interactions, remember that high phosphate indirectly triggers bone resorption by lowering ionized calcium, not by directly affecting bone cells.

Question 19

1. Increased calcitonin secretion to stimulate osteoclasts and raise serum Ca2+
2. Decreased PTH secretion because low Ca2+ suppresses parathyroid activity
3. Increased PTH secretion because low serum Ca2+ stimulates the parathyroid glands (correct answer)
4. No change in PTH secretion because PTH release depends only on serum phosphate

Explanation: This question evaluates understanding of compensatory hormonal responses when PTH action is blocked. The skeletal system's mineral homeostasis depends on PTH's ability to mobilize calcium through bone resorption and optimize calcium-phosphate balance through renal effects. When PTH receptors are blocked, its calcium-raising actions are prevented, leading to mild hypocalcemia as described. This low calcium state is detected by calcium-sensing receptors on the parathyroid glands, which respond by increasing PTH secretion in an attempt to overcome the receptor blockade. Choice B incorrectly states that low calcium suppresses PTH, when it actually stimulates it, while choice D wrongly claims PTH depends only on phosphate. For hormone feedback questions, remember that calcium and PTH have an inverse relationship: low calcium stimulates PTH release, while high calcium suppresses it.

Question 20

1. Increased serum Ca2+ due to enhanced osteoclast-mediated mineral release
2. Decreased serum Ca2+ due to reduced bone resorption and reduced mineral release (correct answer)
3. Increased serum phosphate due to PTH-like stimulation of bone resorption
4. No change in serum minerals because calcitonin acts only on osteoblasts

Explanation: This question evaluates understanding of calcitonin's effects on bone resorption and mineral homeostasis. The skeletal system maintains mineral balance through hormonal regulation of bone cell activity, with calcitonin serving as a calcium-lowering hormone. The calcitonin mimetic inhibits osteoclast activity, reducing their ability to resorb mineralized bone matrix. This decreased resorption means less calcium and phosphate are released from the skeletal reservoir into the bloodstream, leading to reduced serum calcium levels. Choice A incorrectly predicts increased calcium from reduced resorption, while choice D wrongly states calcitonin acts on osteoblasts rather than osteoclasts. For hormone action questions, match the hormone to its target cell and effect: calcitonin targets osteoclasts to inhibit resorption, thereby reducing mineral release and lowering serum calcium.